周一报道，DeliverSpring宣布2025年指导方针：115亿美元-120亿美元（东部时间12.68亿美元）收入和5.4亿美元-5.55亿美元调整后EBITDA; SEARCH 2024年收入达到112亿美元-113亿美元（预计11.175亿美元），调整后EBITDA为5.88亿美元

Preliminary Full Year 2024 Results and 2025 Guidance

Based on our preliminary review of fourth quarter results, the Company expects to report full year 2024 financial results above the guidance it previously provided in its press release dated November 1, 2024, as follows:

• Net Revenue of $11,200 million to $11,300 million, or 26.9% to 28.0% growth over full year 2023
  • Pharmacy Segment Revenue of $8,700 million to $8,750 million, or 33.4% to 34.2% growth over full year 2023
  • Provider Segment Revenue of $2,500 million to $2,550 million, or 8.5% to 10.7% growth over full year 2023; Community Living Revenue in 2024 is expected to be $1.2 billion
• Adjusted EBITDA2 of approximately $588 million or 15.8% growth over full year 2023, excluding the impact from a certain Quality Incentive Payment in 2023; Community Living Adjusted EBITDA in 2024 is expected to be approximately $128 million

These preliminary full year 2024 results are unaudited and subject to the finalization of the Company's regular financial and accounting procedures.

For the full year 2025, BrightSpring is initiating guidance, which excludes the Community Living business and the effects of any future closed acquisitions. All growth rates are calculated based off the midpoint of 2024 guidance, excluding the Community Living business.

• Net Revenue of $11,500 million to $12,000 million, or 14.4% to 19.3% growth over full year 2024
  • Pharmacy Segment Revenue of $10,050 million to $10,500 million, or 15.2% to 20.3% growth over full year 2024
  • Provider Segment Revenue of $1,450 million to $1,500 million, or 8.9% to 12.7% growth over full year 2024
• Adjusted EBITDA2 of $540 million to $555 million, or 17.4% to 20.7% growth over full year 2024 (of approximately $460 million of expected 2024 Company Adjusted EBITDA excluding Community Living)